Brambles Adr Earnings Calls
| Release date | Feb 18, 2026 |
| EPS estimate | $0.706 |
| EPS actual | $0.740 |
| EPS Surprise | 4.82% |
| Revenue estimate | 3.55B |
| Revenue actual | 3.534B |
| Revenue Surprise | -0.456% |
| Release date | Oct 24, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Release date | Aug 20, 2025 |
| EPS estimate | $0.585 |
| EPS actual | $0.429 |
| EPS Surprise | -26.74% |
| Revenue estimate | 3.344B |
| Revenue actual | 2.248B |
| Revenue Surprise | -32.76% |
| Release date | Aug 20, 2025 |
| EPS estimate | $0.585 |
| EPS actual | $0.600 |
| EPS Surprise | 2.56% |
| Revenue estimate | 3.344B |
| Revenue actual | 3.298B |
| Revenue Surprise | -1.38% |
Last 4 Quarters for Brambles Adr
Below you can see how BXBLY performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 20, 2025 |
| Price on release | $30.00 |
| EPS estimate | $0.585 |
| EPS actual | $0.600 |
| EPS surprise | 2.56% |
| Date | Price |
|---|---|
| Aug 14, 2025 | $29.94 |
| Aug 15, 2025 | $30.13 |
| Aug 18, 2025 | $30.18 |
| Aug 19, 2025 | $30.13 |
| Aug 20, 2025 | $30.00 |
| Aug 21, 2025 | $33.53 |
| Aug 22, 2025 | $33.74 |
| Aug 25, 2025 | $33.97 |
| Aug 26, 2025 | $33.97 |
| 4 days before | 0.200% |
| 4 days after | 13.23% |
| On release day | 11.77% |
| Change in period | 13.46% |
| Release date | Aug 20, 2025 |
| Price on release | $30.00 |
| EPS estimate | $0.585 |
| EPS actual | $0.429 |
| EPS surprise | -26.74% |
| Date | Price |
|---|---|
| Aug 14, 2025 | $29.94 |
| Aug 15, 2025 | $30.13 |
| Aug 18, 2025 | $30.18 |
| Aug 19, 2025 | $30.13 |
| Aug 20, 2025 | $30.00 |
| Aug 21, 2025 | $33.53 |
| Aug 22, 2025 | $33.74 |
| Aug 25, 2025 | $33.97 |
| Aug 26, 2025 | $33.97 |
| 4 days before | 0.200% |
| 4 days after | 13.23% |
| On release day | 11.77% |
| Change in period | 13.46% |
| Release date | Oct 24, 2025 |
| Price on release | $32.25 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Oct 20, 2025 | $32.79 |
| Oct 21, 2025 | $32.79 |
| Oct 22, 2025 | $32.14 |
| Oct 23, 2025 | $32.17 |
| Oct 24, 2025 | $32.25 |
| Oct 27, 2025 | $32.76 |
| Oct 28, 2025 | $33.06 |
| Oct 29, 2025 | $32.33 |
| Oct 30, 2025 | $32.12 |
| 4 days before | -1.65% |
| 4 days after | -0.419% |
| On release day | 1.58% |
| Change in period | -2.06% |
| Release date | Feb 18, 2026 |
| Price on release | $33.25 |
| EPS estimate | $0.706 |
| EPS actual | $0.740 |
| EPS surprise | 4.82% |
| Date | Price |
|---|---|
| Feb 11, 2026 | $32.97 |
| Feb 12, 2026 | $32.50 |
| Feb 13, 2026 | $33.09 |
| Feb 17, 2026 | $33.54 |
| Feb 18, 2026 | $33.25 |
| Feb 19, 2026 | $34.56 |
| Feb 20, 2026 | $34.42 |
| Feb 23, 2026 | $34.70 |
| Feb 24, 2026 | $35.22 |
| 4 days before | 0.85% |
| 4 days after | 5.92% |
| On release day | 3.94% |
| Change in period | 6.82% |
Brambles Adr Earnings Call Transcript Summary of Q4 2025
Brambles reported a solid FY'25 with sales revenue up 3%, underlying profit up 10%, and free cash flow before dividends exceeding US$1.0bn for the first time. Management highlighted successful delivery of its Shaping Our Future transformation: material asset-efficiency improvements (pooling CapEx/sales down, uncompensated pallet losses ~50% lower vs FY'21), digital advances (autonomous trackers, Serialisation+ pilots) and improved customer metrics (NPS, on‑time delivery). The board declared a 17% higher dividend and completed US$403m buybacks, and approved up to US$400m additional buybacks for FY'26. FY'26 guidance: sales growth 3–5%, underlying profit growth 8–11%, free cash flow before dividends US$850–950m, pooling CapEx/sales ~14–16% (including a ~0.5pp benefit from using excess U.S. plant stock). Management will invest in Serialisation+ read infrastructure (prioritizing U.S. reads in FY'26) while targeting a ROCI hurdle of at least 15% for Serialisation+ rollout; they will be selective on tagging until lower‑cost device trials conclude. The company expects margin expansion (targeting at least +3pp vs FY'24 by FY'28) driven by continued asset, supply chain and overhead productivity, alongside a FY'26 overhead restructuring (c. US$30m cost in H1 delivering a net ~US$15m benefit in FY'26 and ~US$55m annualized from FY'27). Key risks: macro uncertainty depressing like‑for‑like volumes, U.S. excess pallets (c.4m) normalizing by H1 FY'27, and FIFO pallet cost increasing IPEP to ~1.6% of sales in FY'26.
Sign In
Buy BXBLY